Curt Bradshaw
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Curt Bradshaw
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 9 | |
Solstice Biologics LLC
Solstice Biologics LLC Pharmaceuticals: MajorHealth Technology Solstice Biologics LLC develops nucleic acid therapeutics. It specializes in the development of small, cell-permeable RNAi pro-drugs. The company was founded by Steven Dowdy and Curt W. Bradshaw in 2012 and is headquartered in San Diego, CA.
4
| Extinct | Pharmaceuticals: Major | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Curt Bradshaw
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
SEMBIOSYS GENETICS I | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
ATHIRA PHARMA, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
University of Buenos Aires School of Medicine | College/University | Doctorate Degree | |
ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ALDER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of California San Diego | College/University | Corporate Officer/Principal | |
University of California, Irvine | College/University | Doctorate Degree | |
Sensovation AG
Sensovation AG Electronic Equipment/InstrumentsElectronic Technology Sensovation AG manufactures and supplies scientific imaging instrumentation products. The firm specializes in the development and production of scientific imaging and low light detection solutions, based on charge coupled device and complementary metal oxide semiconductor technologies. It offers automated digital microscopes, microarray analyzers, and scientific cameras for bioimaging, diagnostics, and quality control in clean technology applications. It also engages in partnerships focused on building and supplying commercial production systems and platforms. The company was founded by Stefan Bickert and Paul Hing in 2000 and is headquartered in Radolfzell, Germany. | Electronic Equipment/Instruments | Chairman | |
KODIAK SCIENCES INC. | Biotechnology | Director of Finance/CFO | |
CURETIS N.V. | Medical/Nursing Services | Director/Board Member | |
EMBL Ventures GmbH
EMBL Ventures GmbH Investment ManagersFinance EMBL Ventures GmbH (EMBL Ventures) is a venture investment arm of EMBL which was founded in 2001 by Drs. Stefan Herr, Christoph Antz and Jan Adams to provide start-up companies exploiting EMBL research and intellectual property with equity and expertise to build up and expand their business. Headquartered in Heidelberg, EMBL Ventures manages funds on behalf of institutional and private investors, forming a triad with EMBL (European Molecular Biology Laboratory) and EMBLEM (EMBL Enterprise Management Technology Transfer GmbH) to provide exclusive access to unique technology commercialization opportunities from the EMBL. In addition, their investment activities complement and exploit synergies with EMBL and EMBLEM, providing financial and strategic investors with access to an attractive private equity market and an international scientific and research community, respectively. | Investment Managers | Private Equity Investor | |
AFFIMED N.V. | Biotechnology | Director/Board Member | |
CONFORMIS, INC. | Medical Specialties | Director/Board Member | |
MITSUBISHI RESEARCH INSTITUTE, INC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Curetis GmbH
Curetis GmbH Medical SpecialtiesHealth Technology Curetis GmbH operates as a molecular diagnostics company which focuses on the development and commercialization of products for diagnosing severe infectious diseases. The firm offers diagnostic solutions for hospitals and large-scale laboratories. Its products include Unyvero L4 Lysator, Unyvero C8 Cockpit, Unyvero A50 Analyzer, and Unyvero Application Cartridges. The company was founded by Andreas Boos, Johannes Bacher, Gerd Lüdke, and Anne Thews in August 2007 and is headquartered in Holzgerlingen, Germany. | Medical Specialties | Chairman | |
Affimed NV Niederlassung Deutschland
Affimed NV Niederlassung Deutschland Pharmaceuticals: MajorHealth Technology Affimed NV Niederlassung Deutschland discovers and develops antibody-based therapeutic drugs. The firm generates and develops a pipeline of antibody product candidates based on proprietary technology platform. It offer therapeutic drugs that target autoimmune diseases and tumor cells. The company was founded in 2000 and is headquartered in Heidelberg, Germany. | Pharmaceuticals: Major | Director/Board Member | |
The University At Buffalo School of Management | College/University | Masters Business Admin | |
Agenovir Corp.
Agenovir Corp. Pharmaceuticals: MajorHealth Technology Agenovir Corp. provides research and developing novel antiviral therapeutics for diseases. The company was founded by Bruce Hironaka and Stephen R. Quake and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
MIT Sloan School of Management | College/University | Masters Business Admin | |
KARYOPHARM THERAPEUTICS INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
CRINETICS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
MEDIVATION INC | Pharmaceuticals: Major | Sales & Marketing | |
Nova Southeastern University, Inc. | College/University | Masters Business Admin | |
University of Toronto | College/University | Undergraduate Degree | |
COHERUS BIOSCIENCES, INC. | Pharmaceuticals: Major | Sales & Marketing | |
BlueRock Therapeutics LP
BlueRock Therapeutics LP Miscellaneous Commercial ServicesCommercial Services Part of Bayer AG, BlueRock Therapeutics LP is a clinical stage cell therapy company based in Cambridge, MA. The company is focused on creating cellular medicines to reverse devastating diseases such as neurological, cardiovascular, immunological, and ophthalmic diseases. BlueRock Therapeutics's lead clinical program, Bemdaneprocel, is in phase I clinical trials for Parkinson's disease. In late 2019, BlueRock became a wholly owned, independently operated subsidiary of Bayer AG as a cornerstone of its newly formed cell & gene therapy platform. The company's culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that they are all part of something bigger than themselves. The company was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer, the impact investing arm of Bayer AG that invests in paradigm-shifting breakthrough innovation. | Miscellaneous Commercial Services | Director/Board Member | |
VIR BIOTECHNOLOGY, INC. | Biotechnology | Chief Executive Officer | |
Vividion Therapeutics, Inc.
Vividion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Vividion Therapeutics, Inc. operates as a biotechnology company. The company focuses on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome wide drug and target discovery. It's proprietary chemoproteomic platform technology addresses the key limitations of conventional screening techniques and allows the discovery of previously unknown, or cryptic, functional pockets on the surface of proteins and identification of small molecules that selectively bind to those targets. The company was founded by Benjamin F. Cravatt, Phil S. Baran, Jin-Quan Yu and John K. Clarke on December 24, 2013 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
KRONOS BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
Asklepios BioPharmaceutical, Inc.
Asklepios BioPharmaceutical, Inc. BiotechnologyHealth Technology Asklepios BioPharmaceutical, Inc. operates as a gene therapy-based company. It engages in capsid development, scaled manufacturing, and a portfolio of therapeutic programs. The company was founded by Richard Jude Samulski, Xiao Xiao, and Sheila A. Mikhail in 2001 and is headquartered in Durham, NC. | Biotechnology | Director/Board Member | |
Vrije Universiteit Brussel | College/University | Graduate Degree | |
Gladstone Foundation (CA) | Director/Board Member | ||
Rotterdam School of Management | College/University | Masters Business Admin | |
Ghent University | College/University | Doctorate Degree | |
EcoHealth Alliance, Inc.
EcoHealth Alliance, Inc. Miscellaneous Commercial ServicesCommercial Services EcoHealth Alliance, Inc. operates a not for profit organization. It protects the health of people, animals, and the environment. Its programs include rift valley fever, predict, health and policy initiatives, monitoring the deadly Nipah virus, emerging disease hotspots, project deep forest, ecohealthy pets, global wildlife trade, and economics of emerging infectious diseases. The company is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member | |
Rochester Institute of Technology
Rochester Institute of Technology Other Consumer ServicesConsumer Services Rochester Institute of Technology is a privately endowed, coeducational university with ten colleges emphasizing career education and experiential learning. It was founded in 1829 and is headquartered in Rochester, NY. | College/University | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 31 |
Deutschland | 9 |
Kanada | 3 |
Belgien | 3 |
Argentinien | 2 |
Sektoral
Health Technology | 25 |
Consumer Services | 12 |
Commercial Services | 7 |
Electronic Technology | 2 |
Health Services | 2 |
Operativ
Director/Board Member | 45 |
Corporate Officer/Principal | 22 |
Chief Tech/Sci/R&D Officer | 12 |
Independent Dir/Board Member | 12 |
Chief Executive Officer | 12 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Adeoye Olukotun | 24 |
Bruce Given | 16 |
Frank Mühlenbeck | 16 |
Lou Tartaglia | 15 |
Marianne de Backer | 14 |
Javier San Martin | 7 |
James Hassard | 7 |
John Borgeson | 6 |
Sohanya Cheng | 5 |
Steven F. Dowdy | 4 |
Randy Steiner | 1 |
Jeff Ketelhut | 1 |
Matt Pulisic | 1 |
- Börse
- Insiders
- Curt Bradshaw
- Unternehmensverbindungen